SYNTIS BIO, INC.

Profile

Company Names

SYNTIS BIO, INC.

Addresses

135 MORRISSEY BLVD, SUITE 101A, BOSTON, MA 02125

135 MORRISSEY BOULEVARD, SUITE 101A, BOSTON, MA 02125

50 ADAMS STREET, SUITE 870073, MILTON, MA 02187

Phone Numbers

857-675-1109
617-834-8247

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$46,672,163.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-06-17 
$24,983,429.00 
$26,483,445.00 
$1,500,016.00 
Equity 
2
2024-12-30 
$6,316,555.00 
$9,000,000.00 
$2,683,445.00 
Equity 
1
2022-08-03 
$15,372,179.00 
$15,372,179.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAHUL 
 
DHANDA 
EXECUTIVE OFFICER, DIRECTOR
RAHUL 
K. 
DHANDA 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
MARTIN 
 
MADAUS 
DIRECTOR
MICHAEL 
 
NANNIZZI 
DIRECTOR
CARLO 
GIOVANNI 
TRAVERSO 
DIRECTOR
CARLO GIOVANNI 
 
TRAVERSO 
DIRECTOR
CHENNY 
 
ZHANG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#